Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
作者信息
Bai Bing, Wang Xusheng, Li Yuxin, Chen Ping-Chung, Yu Kaiwen, Dey Kaushik Kumar, Yarbro Jay M, Han Xian, Lutz Brianna M, Rao Shuquan, Jiao Yun, Sifford Jeffrey M, Han Jonghee, Wang Minghui, Tan Haiyan, Shaw Timothy I, Cho Ji-Hoon, Zhou Suiping, Wang Hong, Niu Mingming, Mancieri Ariana, Messler Kaitlynn A, Sun Xiaojun, Wu Zhiping, Pagala Vishwajeeth, High Anthony A, Bi Wenjian, Zhang Hui, Chi Hongbo, Haroutunian Vahram, Zhang Bin, Beach Thomas G, Yu Gang, Peng Junmin
出版信息
Neuron. 2020 May 20;106(4):700. doi: 10.1016/j.neuron.2020.04.031.
Abstract
摘要
相似文献
1
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.深度多层脑蛋白质组学揭示阿尔茨海默病进展中的分子网络。
Neuron. 2020 May 20;106(4):700. doi: 10.1016/j.neuron.2020.04.031.
2
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.阿尔茨海默病大脑中的氧化应激：氧化还原蛋白质组学的新见解
Eur J Pharmacol. 2006 Sep 1;545(1):39-50. doi: 10.1016/j.ejphar.2006.06.026. Epub 2006 Jun 15.
3
Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity.阿尔茨海默病的局部脑血流：异质性的分类与分析
Dement Geriatr Cogn Disord. 2004;17(3):207-14. doi: 10.1159/000076358. Epub 2004 Jan 20.
4
Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.整合蛋白质组学和网络分析鉴定阿尔茨海默病中的蛋白质枢纽和网络改变。
Acta Neuropathol Commun. 2018 Mar 1;6(1):19. doi: 10.1186/s40478-018-0524-2.
5
Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.阿尔茨海默病中海马和后枢纽区的选择性损伤：基于 MEG 的多重网络研究。
Brain. 2017 May 1;140(5):1466-1485. doi: 10.1093/brain/awx050.
6
Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.蛋白质组学分析鉴定出与阿尔茨海默病中毛细血管脑淀粉样血管病相关的新标志物。
Acta Neuropathol Commun. 2018 Jun 4;6(1):46. doi: 10.1186/s40478-018-0540-2.
7
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.网络驱动的血浆蛋白质组学揭示了阿尔茨海默病大脑中的分子变化。
Mol Neurodegener. 2016 Apr 26;11:31. doi: 10.1186/s13024-016-0095-2.
8
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.对19个脑区的综合网络分析确定了阿尔茨海默病选择性区域易损性背后的分子特征和网络。
Genome Med. 2016 Nov 1;8(1):104. doi: 10.1186/s13073-016-0355-3.
9
Networks of tau distribution in Alzheimer's disease.阿尔茨海默病中的 tau 分布网络。
Brain. 2018 Feb 1;141(2):568-581. doi: 10.1093/brain/awx353.
10
Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).氧化还原蛋白质组学鉴定阿尔茨海默病大脑以及以β淀粉样蛋白（1-42）为核心的阿尔茨海默病体内和体外模型中氧化修饰的蛋白质。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Mar 20;833(1):3-11. doi: 10.1016/j.jchromb.2005.09.024. Epub 2005 Oct 17.
引用本文的文献
1
Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer's patient-derived cortical neurons.在源自阿尔茨海默病患者的皮质神经元中，升高的血清糖皮质激素诱导激酶1（SGK1）会增加 Tau 蛋白磷酸化并导致微管不稳定。
Mol Psychiatry. 2025 Sep 8. doi: 10.1038/s41380-025-03225-4.
2
Distinct composition of different types of Abeta plaques in the pathogenesis of Alzheimer's disease and the role of neutrophil-derived myeloperoxidase.不同类型β-淀粉样蛋白斑块在阿尔茨海默病发病机制中的独特组成以及中性粒细胞衍生的髓过氧化物酶的作用。
Mol Brain. 2025 Jun 22;18(1):53. doi: 10.1186/s13041-025-01226-6.
3
The Role of Intermittent Fasting in the Activation of Autophagy Processes in the Context of Cancer Diseases.间歇性禁食在癌症疾病背景下自噬过程激活中的作用。
Int J Mol Sci. 2025 May 15;26(10):4742. doi: 10.3390/ijms26104742.
4
Neurodegeneration in acute and chronic central nervous system disorders: Novel ideas and approaches.急性和慢性中枢神经系统疾病中的神经退行性变：新观点与新方法
Neuroprotection. 2024 Dec;2(4):243-245. doi: 10.1002/nep3.69. Epub 2024 Dec 16.
5
Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions.小鼠组织和脑区蛋白质组及磷酸化蛋白质组的周转图谱。
Cell. 2025 Apr 17;188(8):2267-2287.e21. doi: 10.1016/j.cell.2025.02.021. Epub 2025 Mar 20.
6
Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.富含肝素的血浆蛋白质组在阿尔茨海默病中发生显著改变。
Mol Neurodegener. 2024 Oct 8;19(1):67. doi: 10.1186/s13024-024-00757-1.
7
CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.脑脊液补体蛋白在阿尔茨海默病前驱期至中度患者中升高，而抗 tau 抗体 semorinemab 不会改变其水平。
Alzheimers Dement. 2024 Nov;20(11):7940-7953. doi: 10.1002/alz.14271. Epub 2024 Oct 6.
8
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease.综合蛋白质组学鉴定出阿尔茨海默病中保守的 Aβ 淀粉样蛋白反应组、新型斑块蛋白和病理修饰物。
Cell Rep Med. 2024 Aug 20;5(8):101669. doi: 10.1016/j.xcrm.2024.101669. Epub 2024 Aug 9.
9
The emerging role of the HTRA1 protease in brain microvascular disease.HTRA1蛋白酶在脑微血管疾病中的新作用。
Front Dement. 2023 Apr 12;2:1146055. doi: 10.3389/frdem.2023.1146055. eCollection 2023.
10
Impaired biogenesis of basic proteins impacts multiple hallmarks of the aging brain.碱性蛋白质生物合成受损影响衰老大脑的多个特征。
bioRxiv. 2024 Jan 9:2023.07.20.549210. doi: 10.1101/2023.07.20.549210.
Zotero 插件